Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

A multi-institutional research team led by Osaka University found that tricaprin, a natural supplement, improved long-term ...

“The most significant is coronary artery disease, where lipid buildup causes blockages in the heart’s arteries. These blockages can lead to heart attacks or angina—chest pain that occurs ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

Fact checked by Nick Blackmer A study found that typical cholesterol tests measuring HDL and LDL levels might be missing an ...

Heart disease claims more lives in America than any other medical problem every year, therefore keeping your heart and ...

Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the risk factors associated with ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Wu and colleagues confirmed that cultured-microglia-carrying lipid droplets struggled with phagocytosis, poorly engulfing ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...